StockData
PBMNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBMWW

PSYENCE BIOMEDICAL LTD.

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 22, 2026
$4.12−0.10 (-2.37%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Psyence Biomedical has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Psyence Biomedical filed with the SEC